Return
Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy
DOI:10.1016/j.juro.2012.03.007.png)
Abstract
En 中文
Purpose: We assessed the impact of hexaminolevulinate fluorescence cystoscopic detection of papillary, nonmuscle invasive bladder cancer on the long-term recurrence rate. Materials and Methods: Long-term followup was assessed in 551 participants enrolled in a prospective, randomized study of fluorescence cystoscopy for Ta or T1 urothelial bladder cancer. In the original study 280 patients in the white light cystoscopy group and 271 in the fluorescence cystoscopy group were followed with cystoscopy for 3, 6 and 9 months after initial resection or until recurrence. A study extension protocol was done for long-term followup of these patients. Results: Followup information was obtained for 261 of the 280 patients (93%) in the white light group and 255 of the 271 (94%) in the fluorescence group. Median followup in the white light and fluorescence groups was 53.0 and 55.1 months, and 83 (31.8%) and 97 patients (38%) remained tumor free, respectively. Median time to recurrence was 9.4 months in the white light group and 16.4 months in the fluorescence group (p = 0.04). The intravesical therapy rate was similar in the 2 groups (46% and 45%, respectively). Cystectomy was done in 22 of 280 cases (7.9%) in the white light group and in 13 of the 271 (4.8%) in the fluorescence group (p = 0.16). Conclusions: Hexaminolevulinate fluorescence cystoscopy significantly improves long-term bladder cancer time to recurrence with a trend toward improved bladder preservation.
Keywords:
urinary bladder neoplasms
5-aminolevulinic acid hexyl ester
fluorescence
cystoscopy
neoplasm recurrence, local
Journal
IF:
6.8
Papers:
6.6W
Citations:
4.9W
Organization
Cited Papers
Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer EDITORIAL COMMENT
JOURNAL OF UROLOGY
IF6.8
Hexyl aminolevulinate fluorescence cystoscopy:: A new diagnostic tool for the photodiagnosis of superficial bladder cancer -: A multicenter study
JOURNAL OF UROLOGY
IF6.8
Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
BJU INTERNATIONAL
IF4.4
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy
JOURNAL OF UROLOGY
IF6.8
Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer
JOURNAL OF UROLOGY
IF6.8

